CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest. Supporting Information Filename Description vec13324-sup-0001-TablesS1-S2.docx12.8 KB Supporting Information REFERENCES 1, , . Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc. 2008; 83: 1032-1045. 2, , , et al. Bisphosphonate use in the horse: what is good and what is not? BMC Vet Res. 2019; 15: 211. 3 FDA Freedom of Information Summary: Tildren, tiludronate disodium. 2014; NADA: 141-420.